Reconstituted: 28 C, use within 14 days
ebei, B., Nikoli, V., Sikiric, P., Seiwerth, S., oa, T., Patrlj, L., Grabarevi, ., Ruman, R., Petek, M., Konjevoda, P., Jadrijevi, S., Perovi, D., & laj, M
In Vitro Evidence In 2016, Lima and colleagues studied the CA ability to not only inhibit the growth and vitality of two different bacteria strains responsible to cause UTI (e.g., UPEC 06 (EC06), isolated from urine culture, and Pseudomonas eruginosa15 (PA15), isolated from the catheter tip), but also its capacity to enhance the activity of conventional antimicrobial drugs [89]
BPC-157 is a research-stage peptide without extensive human clinical trials